SCHEMBL6326570

SCHEMBL6326570

O=C(CCc1nc(-c2ccc(Cl)cc2)no1)NCCNc1n[nH]c(=O)c2ccccc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 4/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.53
▸ CYP1A2 P05177 1/20 0.52
▸ CYP2D6 P10635 1/20 0.52
▸ CYP2C9 P11712 1/20 0.52
▸ CYP2C19 P33261 1/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ LMNA P02545 4/20 0.49
▸ ALDH1A1 P00352 4/20 0.49
▸ HPGD P15428 2/20 0.49
▸ AURKB Q96GD4 1/20 0.49
▸ CNR2 P34972 2/20 0.47
▸ USP2 O75604 2/20 0.47
▸ HTT P42858 2/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ GAA P10253 3/20 0.46
▸ HDAC1 Q13547 1/20 0.46
▸ HDAC2 Q92769 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ TP53 P04637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6323594 0.95 TSHR (0.51) TSHRSMN1; SMN2CYP1A2CYP2D6CYP2C9
SCHEMBL6324086 0.95 HDAC1 (0.52) TSHRSMN1; SMN2CYP1A2CYP2D6CYP2C9
SCHEMBL6333112 0.95 TSHR (0.51) TSHRSMN1; SMN2CYP1A2CYP2D6CYP2C9
SCHEMBL6323211 0.93 CYP1A2 (0.60) TSHRSMN1; SMN2CYP1A2CYP2D6CYP2C9
SCHEMBL6332451 0.92 CYP1A2 (0.48) TSHRSMN1; SMN2CYP1A2CYP2D6CYP2C9
SCHEMBL6326417 0.91 TSHR (0.60) TSHRSMN1; SMN2CYP1A2CYP2D6CYP2C9
SCHEMBL6334127 0.91 CYP1A2 (0.52) TSHRSMN1; SMN2CYP1A2CYP2D6CYP2C9
SCHEMBL6328068 0.91 HDAC1 (0.51) TSHRSMN1; SMN2CYP1A2CYP2D6CYP2C9
SCHEMBL6327897 0.91 HDAC1 (0.51) TSHRSMN1; SMN2CYP1A2CYP2D6CYP2C9
SCHEMBL6334322 0.89 CYP1A2 (0.49) TSHRSMN1; SMN2CYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6924284-B2 PARP inhibitors ICOS CORPORATION (US) 2005-08-02 — — US disclosed
Send feedback